Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Uterine
Study Phase
Phase 3
Study Completion Date
December 2015
NCT01672892Uploaded 06-17-2020
Access via NCI by Request
PDS UID: nci-data-418
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Provider Information
Provider Data DescriptionThis dataset contains patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT01672892 to reproduce the results in PubMed ID=29989857.
SponsorRadiation Therapy Oncology Group
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This randomized phase III trial is studying two different methods of radiation and their side effects and comparing how well they work in treating endometrial and cervical cancer after surgery.
ConditionsCervical Cancer
Endometrial Cancer
Gastrointestinal Complications
Perioperative/Postoperative Complications
Radiation Toxicity
Urinary Complications
Urinary Tract Toxicity
Intervention TypeRadiation: Standard radiation therapy
Radiation: intensity-modulated radiation therapy
Drug(s)N/A
Total Enrolled289
RandomizationRandomized
Blinding MethodNone (Open Label)
Arms InterventionIntensity-Modulated Radiation Therapy - Experimental
Standard Radiation Therapy - Active Comparator
Secondary IDCDR0000738944
PubMed (PMID)32073955
31104905
29989857
35960897
Collaborator(s)National Cancer Institute (NCI)
NRG Oncology
Region(s)United States
Canada
Hong Kong
Singapore
Age Range18 Years and older (Adult, Older Adult)
Files: NCT01672892-D1
Data DictionaryNCT01672892-D1-Data-Dictionary_2.pdf
DATANCT01672892-D1-Dataset_1.csv
OTHERREADME.pdf
© 2023 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use